[home]
ATG - your reliable partner for your outsourcing strategy and de novo planning is expert in
In an early phase of strategic marketing or in the course of the market driven innovation product cycles of bioproducts there is a need for new bioproducts with new properties and functions. In pursuing the aim of success for and with our clients and to minimize any risk of failure, in advance of each project we investigate the highest level of knowledge about any topic using our bioTech Infobase, search strategies and evaluation schemes, thereby following stringent rules of project management and documentation.
ATG:biosynthetics is your partner for design, operation and control of "INTEGRATIVE BIOTECH PROJECTS" with high impact on the development of NEW MARKETS based on NEW TECHNOLOGIES for FUTURE ECONOMY.
Our projects are mainly based on synthetic genes as prerequisite for optimised biosyntheses. A main feature is the improvement of the quality of synthesis products itself. In addition optimisation of gene expression is possible either in terms of quantity of gene products or of quality of regulation of gene expression.
For providing our customers with optimised gene function, we offer genes and synthetic gene design in order to provide you with the gene function of your desire leading to optimal features of your expression experiments and production scales.
Our R&D activities especially are strong in protein expression and functional optimisation approaches. ATG is improving your biomolecules as well as organising optimised biosynthesis and production.
We are a Synthetic Biology - Bioengineering and Fermentation consultancy firm acting on the level of service for bioproduct development and organisation of your project for functionally optimizing your biomolecules and organising their biosynthesis in improvement of expression and production optimisation. We are specialists for bioproduct development.
In pursuing the success of our clients and in minimising any risk of failure we perform thorough informational investigations prior to starting a project. This is to provide the highest level of knowledge about any topic using our bioTech-Info-base, search strategies and evaluation schemes. We thereby are following stringent rules of project management and ISO documentation. In the choice of our subcontractors by scored matrix evaluation we have a high selectivity.
Protein optimisation (rational or/and evolutive), regarding stability (biological and chemical half-life period, pharmacokinetics), functionality (modulation of functional parameters), interaction (specificity, selectivity, bond strength), optimisation of gene expression (rational or/and evolutive), gene sequencing, codon usage, secondary structural index, G/C concentration, genetic control elements, modulation of expression efficiency, modulation of tissue specificity, protein characterization, UV/VIS spectroscopy, fluorescence spectroscopy, circular dichroism spectroscopy, HPLC and FPLC analysis/cleaning, fluorescence microscopy, denaturing and native gel electrophoresis, analysis of enzyme activities, analysis of protein stability, protein-protein interaction, ELISA, phage display.
The buisness model of ATG focuses on internationally orientated Marketing & Sales of highly specialized biosynthetic products as BioLogics and bioproducts in fields like medical research, food, environment technologies, technical and cleaning processing and use in science as biocatalytical tools such as technical enzymes: Sales, distribution.
Improvement of their properties, analysis, use and consulting on product development of bioproducts, biologics, enzymes, biological active agents.
[home]